ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,152,000 | +157.1% | 69,600 | -36.8% | 0.11% | +132.6% |
| Q1 2019 | $448,000 | +1257.6% | 110,200 | +781.6% | 0.05% | +1433.3% |
| Q4 2018 | $33,000 | +26.9% | 12,500 | +10.4% | 0.00% | +200.0% |
| Q3 2018 | $26,000 | -52.7% | 11,325 | -8.9% | 0.00% | -80.0% |
| Q2 2018 | $55,000 | -58.3% | 12,425 | -63.9% | 0.01% | -54.5% |
| Q1 2018 | $132,000 | +340.0% | 34,425 | +140.3% | 0.01% | +1000.0% |
| Q4 2017 | $30,000 | -64.3% | 14,324 | -70.9% | 0.00% | -66.7% |
| Q3 2017 | $84,000 | -74.8% | 49,217 | -56.5% | 0.00% | -76.9% |
| Q2 2017 | $333,000 | -55.4% | 113,179 | -60.9% | 0.01% | -58.1% |
| Q1 2017 | $746,000 | +387.6% | 289,559 | +493.8% | 0.03% | +416.7% |
| Q4 2016 | $153,000 | +106.8% | 48,765 | -35.6% | 0.01% | +200.0% |
| Q3 2016 | $74,000 | +174.1% | 75,765 | +744.2% | 0.00% | +100.0% |
| Q2 2016 | $27,000 | -12.9% | 8,975 | -93.5% | 0.00% | -66.7% |
| Q1 2016 | $31,000 | -76.5% | 138,500 | +128.6% | 0.00% | -62.5% |
| Q4 2015 | $132,000 | – | 60,582 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|